Jubilant Life Sciences tumbles 4%; plans to raise upto Rs. 1,300 crore
The Board of Directors of the company are to consider the proposal to issue securities which may include equity shares and/or instruments or securities convertible into, exchangeable with or otherwise linked to the equity shares of the Company, up to an amount of USD 200 million or Rs. 1,300 crores approx.